Greg Cicconetti

Greg Cicconetti

AbbVie Inc - Chicago / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4458883
-
person_outline Greg Cicconetti's MOST POPULAR ARTICLES
1-) Study design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary …ML O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Donoghue, E Braunwald, HD White, P Serruys, PG Steg, ...American heart journal 162 (4), 613-619. e1, 20111082011
2-) The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone …LA Fitzpatrick, CE Dabrowski, G Cicconetti, DN Gordon, S Papapoulos, ...The Journal of Clinical Endocrinology & Metabolism 96 (8), 2441-2449, 2011782011
3-) Ronacaleret, a calcium‐sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal womenLA Fitzpatrick, CE Dabrowski, G Cicconetti, DN Gordon, T Fuerst, ...Journal of Bone and Mineral Research 27 (2), 255-262, 2012552012
4-) Efficacy of an herbal dietary supplement (smooth move) in the management of constipation in nursing home residents: a randomized, double-blind, placebo-controlled studyS Bub, J Brinckmann, G Cicconetti, B ValentineJournal of the American Medical Directors Association 7 (9), 556-561, 2006522006
5-) Simulation practices for adaptive trial designs in drug and device developmentC Mayer, I Perevozskaya, S Leonov, V Dragalin, Y Pritchett, A Bedding, ...Statistics in Biopharmaceutical Research 11 (4), 325-335, 2019272019